Post-approval studies (Phase 4)Enrolling By InvitationNCT07343661
What this trial is testing
Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
Who this might be right for
EGPA - Eosinophilic Granulomatosis With PolyangiitisSevere AsthmaEosinophilic Asthma
Azienda Ospedaliero Universitaria di Cagliari 90